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In recent years, it has become increasingly clear that neutrophils and neutrophil-derived factors play an important role in several forms of experimental gastrointestinal ulceration and inflammation.
For example, neutrophils have been shown to play an important role in the gastrointestinal damage associated with hemorrhagic shock and ischemia-reperfusion (E-17,20,21 ).
Itoh and
Guth (10) demonstrated that the gastric damage induced by hemorrhagic shock could be significantly attenuated by free radical scavengers and inhibitors of oxygen radical generation. More recently, Kvietys et al. (13) demonstrated that neutrophils contribute significantly to the gastric damage induced by 20% ethanol. Wallace and Whittle (28) have suggested previously that neutrophils might contribute to the gastric ulceration induced by platelet-activating factor (PAF). This hypothesis was supported by Etienne et al. (4) , who demonstrated that neutropenic rats were significantly more resistant to the gastric damaging actions of PAF than were normal rats. Thus it is possible that neutrophil activation may be a feature common to many experimental models of gastric and intestinal ulceration.
To our knowledge, no study to date has examined the role of the neutrophil in the damage induced in the stomach by NSAIDs. There is, however, some experimental evidence suggestive of such a role. Kitahora and Guth (12) demonstrated that the application of aspirin to the rat stomach resulted in the appearance in the mucosal microcirculation of white thrombi followed by a slowing of mucosal blood flow. Hemorrhagic erosions subsequently formed in these regions. These observa- tions suggested that neutrophil margination and activation might be occurring during this period and that it might contribute to the subsequent development of hemorrhagic erosions. In the present study, we assessed the effects of neutropenia on the susceptibility to NSAIDinduced damage. We also examined the role of two groups of mediators, leukotrienes and PAF, that have been reported to be capable of activating neutrophils in the development of NSAID-induced gastric erosions.
METHODS
Male Wistar rats weighing 200-225 g were deprived of food, but not water, for 18-22 h before an experiment. Gastric hemorrhagic damage was induced by oral administration of either indomethacin or naproxen. Both NSAIDs were dissolved in 5% sodium bicarbonate. Indomethacin was given at a dose of 20 mg/kg, whereas naproxen was given at a dose of 40 mg/kg. In the control groups, the rats received an equivalent volume (0.1 ml/ 100 g body wt) of the vehicle. In most experiments, damage was assessed 3 h after administration of indomethacin or naproxen. The damage was scored by an observer unaware of the treatment using a system described previously (27) that takes into consideration both the number and size of the lesions. We have previously shown that this estimation of damage correlates well with histological assessment of the damage produced by indomethacin (27).
Time course study of indomethacin-induced gastric damage. Indomethacin was administered orally (20 mg/ kg) to four groups of four rats each, while a fifth group of rats (n = 4) received the vehicle. The groups of indomethacin-treated rats were killed at one of the following times after its administration:
15, 30, 60, or 120 min. The control rats were killed 30 min after administration of the vehicle. Gastric damage was scored, and samples of the corpus region of the stomach were excised for determination of leukotriene B, (LTBJ and 6-ketoprostaglandin F1, (6-keto-PGFI,)
synthesis. The tissue samples were weighed, minced with scissors for 15 s, then suspended in 1.0 ml of 10 mM sodium phosphate buffer (pH 7.4). The samples were then incubated in a shaking water bath (37°C) for 20 min, after which they were centrifuged (30 s, 9,000 g). The supernatant was frozen for subsequent determination of LTB* and 6-keto-PGF,, levels by radioimmunoassay (26). The antibody to 6-keto-PGF,, cross-reacts with PGE2 at 5%, PGFB, at 0.3%, and at CO.Ol% with the other major cyclooxygenase products. The antibody to LTB* cross-reacts with the other lipoxygenase and cyclooxygenase products at <0.4%.
Additional experiments were performed in which staining of damaged vascular endothelium with Monastral Blue was determined at various times after administration of indomethacin.
This marker has been used previously to detect changes in vascular permeability after oral administration of ethanol (22). Rats were given indomethacin (20 mg/kg) orally and were killed 15, 60, or 120 min later (n = 4 per group). Five minutes before the rats were killed, Monastral Blue (3%; 0.1 ml/100 g body wt) was injected intravenously via a tail vein. After the rat was killed, the stomach was rapidly excised, opened by an incision along the greater curvature, and pinned out on a wax platform. The stomach was then immersed in 10% Formalin for 24 h followed by immersion in glycerol for 24 h. The stomach was examined under a light microscope, and the dorsal and ventral sides of the mucosal surface were photographed on color transparency film. The transparencies were coded then projected onto an opaque digitizing tablet attached to a microprocessor. Both the total area of glandular mucosa and the area in which staining with Monastral Blue was evident were determined planimetrically using the digitizing tablet. The total surface area of any hemorrhagic erosions was also determined. The final magnification of the mucosa when planimetry was performed was -x50.
Effects of neutropenia
induced by anti-neutrophil serum. Rats were made neutropenic by an intraperitoneal injection of anti-neutrophil serum (ANS) raised in goat against circulating rat neutrophils (21). The rats in the test group received 0.75 ml of the ANS intraperitoneally 12 h before oral administration of indomethacin or naproxen. This volume of ANS was used because it has previously been shown to reduce circulating neutrophil numbers without significantly altering circulating lymphocyte or erythrocyte numbers (21). Control rats received a similar volume of either normal saline or normal goat serum intraperitoneally at the same time. The normal goat serum was diluted in 0.9% saline so that it had the same concentration of protein [determined by the Bradford technique (2)] as the ANS. A blood sample was taken from a tail vein of each rat before administration of ANS, saline, or normal goat serum and immediately before administration of the NSAID. The sample was smeared on a glass slide and stained with a modified Wright's stain (Leukostain; Fisher Scientific). The slides were coded to avoid observer bias then examined under a xl00 objective of a light microscope. The number of neutrophils in 50 fields of view, selected by Vernier coordinates, were counted. Gastric damage induced by the NSAIDs was assessed 3 h after NSAID administration by an observer unaware of the treatment.
An additional group of four rats received indomethacin 12 h after intraperitoneal administration of ANS, as above. These rats were killed 15 min after indomethacin administration, but were given Monastral Blue 5 min before being killed, and the extent of vascular staining with Monastral Blue was determined as described above.
Since gastric damage induced by NSAIDs appears to be a process dependent on the presence of luminal acid, experiments were performed to determine the effects of ANS on gastric acid secretion. Rats pretreated with ANS 12 h earlier (n = 4) and control rats (untreated, n = 4) were anesthetized with pentobarbital sodium (60 mg/kg ip). A laparotomy was performed, and the pylorus was ligated. The rat was then left for 3 h, with body temperature maintained at 37°C through the use of heat lamps. Pedal reflexes were periodically monitored, and when necessary additional pentobarbital sodium was administered. At the end of the 3-h period the esophagus was clamped and the stomach was excised with care taken to preserve the luminal contents of the stomach. The vol-G464 NEUTROPHILS AND NSAID-INDUCED ULCER ume of the luminal fluid was measured. A 20-pl sample of the luminal fluid was then diluted in 20 ml of distilled water, and the concentration of acid was determined by titration to pH 7.0 with 0.01 M NaOH using an automated titration apparatus (Metrohm). The total amount of titratable acid present in the sample of gastric juice was then calculated.
Effects of reduction of circulating neutrophil numbers by methotrexate. Groups of five rats were treated with methotrexate using a dosing regimen described previously (9) . The rats received methotrexate (2.5 mg l kg* -' l day-' ip) or the vehicle (normal saline) each day for 3 days. Blood samples were taken from a tail vein for estimation of circulating neutrophil numbers (as above) on the day after the final dose of methotrexate or saline and each day thereafter. On the third and fifth days after methotrexate administration, the susceptibility to indomethacin-induced gastric damage was assessed. A blood sample was taken from a tail vein, then indomethacin was administered (20 mg/kg PO). The rats were killed 3 h later for assessment of gastric damage. and gastric damage was assessed. These doses of WEB 2086 were selected because in pilot experiments we found that they were effective as inhibitors of PAF-induced hemoconcentration in rats. Briefly, PAF was infused intravenously (100 ng* kg-'* min-') into anesthetized rats for a period of 10 min. The rats were pretreated with WEB 2086 (3 or 20 mg/kg ip) or the vehicle 15 min before the infusion of PAF (n = 5 per group). Blood samples for hematocrit determination were taken before and 30 min after completion of the PAF infusion. In control rats, PAF infusion caused an LTB4, and the MK-571 were obtained from Merck-Frosst (Pointe Claire, Canada). Indomethacin, naproxen, and Monastral Blue were obtained from Sigma Chemical (St. Louis, MO). The antiserum to 6-keto-PGF,, and the unlabeled 6-keto-PGF,, were obtained from Cayman Chemical (Ann Arbor, MI). Labeled LTBl and 6-keto-PGF1, were obtained from Amersham (Oakville, Canada). All other reagents were purchased from Fisher Scientific (Edmonton, Canada).
RESULTS
Time course study of indomethacin-induced gastric damage. Within 15 min of oral administration of indomethacin, gastric cyclooxygenase activity was significantly inhibited. In control rats, the mean level of synthesis of 6-keto-PGF1, was 4,200 pg/mg tissue, whereas in the rats killed 15 min after treatment with indomethacin the mean level of synthesis of this prostanoid was ~50 pg/mg (>95% reduction; P < 0.05). Gastric synthesis of 6-keto-PGF1, was also significantly depressed in each of the other groups of indomethacin-treated rats (up to 3 h postindomethacin).
In contrast to 6-keto-PGF1,, gastric synthesis of LTB* was not significantly affected by indomethacin at any of the times studied (Fig. 1) .
The severity of gastric hemorrhagic erosions increased with time after indomethacin administration (Fig. 1) . The erosions were invariably linear and confined to the corpus region. They were frequently located on the crests of rugal folds.
Monastral Blue staining was evident in the absence of hemorrhagic necrosis. Examination of transverse secStaining of the vascular endothelium with Monastral Blue was not observed in any of the four control rats that were treated with the vehicle for indomethacin. However, as early as 15 min after indomethacin administration significant Monastral Blue staining was detected (Fig. 2) . With time after indomethacin administration, there were progressively fewer regions in which induced changes in hematocrit at doses of 3 and 20 mg/ kg, respectively.
Effects of a leukotriene D4 receptor antagonist. Groups of five rats each were given the LTD4 antagonist MK-571 (3 mg/kg) (11) or the vehicle (0.9% saline) intraperitoneally 15 min before oral administration of indomethacin. The rats were killed 3 h later, and the extent of gastric damage was assessed. This dose of MK-571 was selected because we have previously found that it completely suppressed LTD4-induced vasoconstriction in the rat stomach (25).
Statistical analysis. All data are expressed as means t SE. Groups of data were compared using Student's t test for unpaired data or with an analysis of variance (ANOVA) followed by a Duncan's multiple range test. tions of mucosae from indomethacin-treated rats revealed that Monastral Blue staining occurred exclusively in blood vessels within the mucosal layer and primarily in those nearest the surface epithelium. When hemorrhagic erosions were observed, Monastral Blue staining was apparent throughout the necrotic region as well as in the adjacent regions of the mucosa.
Effects of neutropenia
induced by anti-neutrophil serum. In control rats killed 3 h after administration of indomethacin or naproxen, the mean gastric damage scores were 29 t 3 and 14 t 5, respectively (Fig. 3) .
Pretreatment with ANS 12 h before administration of the NSAID resulted in a decrease in circulating neutrophi1 numbers to <lo% of control levels (P c 0.001; control level of 11.5 t 1.5 neutrophils/50 fields of view). This state of neutropenia was also evident when neutrophi1 counts were performed 3 h after administration of the NSAIDs. The neutropenic rats were significantly more resistant to the damaging actions of indomethacin or naproxen (Fig. 3) . Treatment with normal goat serum did not significantly affect circulating neutrophil numbers nor did it significantly affect the susceptibility to gastric damage induced by indomethacin or naproxen.
Treatment with ANS did not appear to interfere with the ability of indomethacin to inhibit gastric cyclooxygenase. As shown in Fig. 4 , indomethacin significantly (P < 0.01) reduced gastric 6-keto-PGF,, synthesis regardless of whether or not the rats had been pretreated with ANS. Similarly, ANS did not interfere with the inhibition of gastric prostaglandin synthesis by naproxen (untreated controls, 1,089 t 309 pg/mg; naproxen alone, 31 t 16 pg/mg; naproxen + ANS, 43 t 18 pg/mg).
In neutropenic rats killed 15 min after indomethacin administration, increased staining with Monastral Blue was not observed, whereas -2% of the glandular mucosa showed staining with Monastral Blue in the control rats receiving indomethacin.
It is unlikely that the reduction of NSAID-induced gastric damage in neutropenic rats could be attributable to effects on gastric acid secretion. In experiments in which the pylorus was ligated and the gastric secretions were collected 3 h later, treatment with ANS did not significantly affect the volume (2.1 t 1.1 vs. 1.3 t 0.6 ml in controls) or the acid concentration (158.0 t 98.2 vs. 136.9 t 87.3 peq/ml in controls) of the gastric juice. The total acid output during the 3-h collection period also did not differ significantly between the ANS (330 t 205 peq) and control (182 t 116 peq) groups.
Effects of reduction of circulating neutrophil numbers by methotrexate.
When circulating neutrophils were counted 3 days after the final dose of methotrexate, there was no significant difference from the control levels ( Each group consisted of 4 rats. * * Significant differences from the untreated group (P < 0.01; Student's t test). 5 . Effects of treatment with methotrexate (2.5 mg. kg-l. day-l ip) for 3 days on the circulating neutrophil count and susceptibility to indomethacin-induced gastric damage 3 and 5 days later (n = 5 per group). Control rats (n = 10) were treated with saline in place of methotrexate and were killed on same days as methotrexate-treated rats *, * * Significant differences from control group (* P < 0.05; * * P < Oh; ANOVA and Duncan's multiple range test). 5). However, by the fifth day after the final dose of methotrexate there was a significant decrease (-60%; P < 0.05) in circulating neutrophil numbers. Furthermore, the majority of the neutrophils present in smears from rats treated with methotrexate exhibited hypersegmented nuclei. Indomethacin-induced gastric damage in rats challenged 3 days after methotrexate treatment was not significantly different from that in control rats, whereas that in the rats challenged 5 days after methotrexate was significantly reduced (P c 0.01; Fig. 5 ).
Effects of a PAF antagonist. Treatment with WEB 2086 (3 or 20 mg/kg) before and 75 min after oral administration of indomethacin did not significantly affect the extent of gastric damage. In control rats treated with the vehicle, the mean gastric damage score was 31.8 + 12.0, whereas in the group treated with WEB 2086, the mean gastric damage scores were 38.8 t 6.9 (3 mg/ kg) and 35 t 5 (20 mg/kg).
Effects of a leukotriene D4 antagonist. Treatment with a specific LTD* antagonist did not significantly affect the susceptibility to indomethacin-induced gastric damage. In the five control rats pretreated with the vehicle, the mean gastric damage score was 50.2 t 6.1, which was not significantly different from the mean score of 32.8 t 8.8 observed in the five rats pretreated with MK-571.
DISCUSSION
The present results implicate a role for the circulating neutrophil in the pathogenesis of gastric damage induced by nonsteroidal anti-inflammatory drugs. Reduction of circulating neutrophil numbers by treatment with ANS resulted in a significant reduction of the severity of gastric damage induced by either indomethacin or naproxen. Such an effect was not observed when the rats were treated with normal goat serum, suggesting that the effects of the ANS were specifically related to the reduction of circulating neutrophil numbers. Furthermore, reduction of circulating neutrophil numbers through a nonimmunological means (i.e., treatment with methotrexate) also resulted in a reduction in the susceptibility to indomethacin-induced gastric damage. Although methotrexate treatment did not reduce circulating neutrophil numbers to the same extent as the ANS, it is likely that the function of the remaining circulating neutrophils would have been compromised in methotrexate-treated rats. The reduction of NSAID-induced damage in ANS-treated rats was not attributable to #effects on gastric acid secretion nor was it a consequence of reduced cyclooxygenase inhibition, since gastric 6-keto-PGF1, synthesis was reduced by >95% in both control and ANS-treated rats.
There are several possible mechanisms through which neutrophils might contribute to NSAID-induced gastric ulceration. Neutrophil-derived free radicals have been shown to contribute significantly to the necrosis induced by ischemia-reperfusion in the intestine (15, 16) and to the ulceration induced in the stomach by hemorrhagic shock (10, 20). Free radicals have also been suggested to be involved in the pathogenesis of gastric erosions induced by aspirin (18). As well as directly contributing to tissue necrosis, oxygen-derived free radicals can influence vascular tone by accelerating the inactivation of endothelium-derived relaxing factor (7) and in doing so could alter the resistance of the gastric mucosa to damage. In addition to free radicals, neutrophils can also release proteases that can contribute to gastrointestinal ulceration (17) and to changes in mucosal permeability (24). The studies using Monastral Blue demonstrated that vascular endothelial injury preceded the development of hemorrhagic erosions, and such changes in endothelial integrity were not observed in neutropenic rats. It is therefore possible that the factors responsible for this vascular injury are critically important in the pathogenesis of NSAID-induced ulcers. Whether neutrophilderived proteases contribute to the changes in vascular integrity and ulceration induced by NSAIDs such as indomethacin requires further study. Neutrophils might also contribute to NSAID-induced gastric damage by producing focal ischemia. Neutrophil aggregates were suggested (28) to contribute to the vascular engorgement and resulting hypoperfusion that follows administration of PAF. Neutrophils have similarly been implicated (21) as contributing factors to the ischemia induced in the stomach by hemorrhagic shock. Such a role of neutrophils would also be consistent with the observations of Kitahora and Guth (12). After exposing the rat gastric mucosa to aspirin, they observed the accumulation of white thrombi within the gastric microcirculation before a reduction in mucosal perfusion and the development of hemorrhagic lesions.
Neutrophils can release various lipid mediators that affect vascular tone and permeability and that might contribute to the ulceration induced by NSAIDs. For example, leukotrienes and PAF have been shown (19, 25, 28) to increase the susceptibility of the gastric mucosa to the damaging actions of ethanol. PAF has also been suggested to play an important role as an activator of neutrophils (23) and to promote adhesion of neutrophils to the endothelium (1). In the indomethacin model of gastric injury, however, these mediators do not appear to play an important role. Changes in gastric LTB* synthe-
